About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Melanoma Clinical Trials in Massachusetts | 363 Studies

Clinical Trials MelanomaMassachusetts

Melanoma Clinical Trials in Massachusetts

Find 363 clinical trials for melanoma near Massachusetts. Connect with research centers in your area.

All Melanoma trials nationwide All trials in Massachusetts

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 1-20 of 363 trials

CompletedA Study Of PF-05082566 As A Single Agent And In Combination With RituximabA study of PF-05082566, a 4-1BB agonist monoclonal antibody (mAb), in patients with solid tumors or b-cell lymphomas, and in combination with rituximab in patients with CD20…NCT01307267·Duarte, California and 41 others

Melanoma Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedA Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid TumorsThis is a Phase 1, multiple dose, ascending-dose escalation study and expansion study designed to define a maximum tolerated dose and/or recommended dose of XmAb22841 monotherapy…NCT03849469·Encinitas, California and 27 others

CompletedSWOG-9430: Surgery in Treating Patients With Metastatic MelanomaRATIONALE: Surgery may be effective therapy in treating patients with metastatic melanoma.NCT00002860·Anchorage, Alaska and 123 others

CompletedCollecting Tumor Samples From Patients With Gynecological TumorsThis laboratory study is collecting tumor tissue and blood samples from patients with gynecologic tumors.NCT00897442·Fayetteville, Arkansas and 186 others

CompletedA Study of DF6002 Alone and in Combination With NivolumabThe purpose of this study is to evaluate the safety, tolerability, drug-levels, drug-effects and preliminary anti-tumor activity of DF6002 alone and in combination with Nivolumab…NCT04423029·Orange, California and 31 others

RecruitingA Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)This is an open-label, multicenter Phase 2 study evaluating Navlimetostat (BMS-986504) in participants with advanced and/or metastatic solid tumors that have MTAP deletion.NCT07492680·San Francisco, California and 57 others

CompletedPhase I/II Study of PDR001 in Patients With Advanced MalignanciesThe purpose of this "first-in-human" study of PDR001 was to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of PDR001…NCT02404441·Baltimore, Maryland and 40 others

CompletedTRAQinform Assessment of Immunotherapy ResponseThe intent of this study is to evaluate the actionable information output from the TRAQinform Immuno technology in a prospective, non-interventional clinical study.NCT05819255·Boston, Massachusetts and 1 other

TerminatedHigh-Dose Aldesleukin and Ipilimumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed By SurgeryThis phase II trial studies how well high-dose aldesleukin and ipilimumab works in treating patients with stage III-IV melanoma that cannot be removed by surgery.NCT02203604·Maywood, Illinois and 5 others

CompletedDendritic Cell Activating Scaffold in MelanomaThis research study is a Phase I clinical trial. Phase I clinical trials test the safety of investigational melanoma vaccines.NCT01753089·Boston, Massachusetts and 1 other

TerminatedStudy of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced MalignanciesThis is a Phase 1, open-label, first-in-human study of CTX-471 administered as a monotherapy or in combination with pembrolizumab in patients with metastatic or locally advanced…NCT03881488·Ocala, Florida and 9 others

Active not recruitingA Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced MelanomaThe purpose of this study is to determine whether relatlimab in combination with nivolumab is more effective than nivolumab monotherapy in treating unresectable melanoma or…NCT03470922·Tucson, Arizona and 126 others

CompletedCAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2)The objective of this study is to assess safety and efficacy of CAB-ROR2-ADC in solid tumorsNCT03504488·Tucson, Arizona and 58 others

UnknownGI Complications in Cancer Immunotherapy PatientsThe purpose of this study is to establish a prospective observational cohort of cancer immunotherapy patients with GI side effects in order to identify biomarkers that predict GI…NCT02784366·Boston, Massachusetts

RecruitingORACLE: Observation of ResiduAl Cancer With Liquid Biopsy EvaluationThe purpose of ORACLE is to demonstrate the ability of a novel ctDNA assay developed by Guardant Health to detect recurrence in individuals treated for early-stage solid tumors.NCT05059444·Birmingham, Alabama and 56 others

CompletedA Pharmacokinetic Study of RO5185426 in Combination With a Drug Cocktail in Patients With Metastatic MelanomaThis open-label single-arm study will evaluate the effect of RO5185426 \[RG7204; PLEXXIKON: PLX4032\] on the pharmacokinetics of five CYP450 substrates (caffeine, warfarin +…NCT01001299·Los Angeles, California and 4 others

TerminatedIMM60 and Pembrolizumab in Melanoma and NSCLCThe goal of this clinical trial is to learn about IMM60 with or without pembrolizumab in participants with advanced melanoma or non-small cell lung cancer.NCT05709821·Los Angeles, California and 13 others

RecruitingA Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory MelanomaThe goal of this clinical trial is to understand if a new drug called LNS8801 can safely treat patients with melanoma.NCT06624644·Newport Beach, California and 8 others

TerminatedStudy of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid TumorsTo determine the recommended Phase 2 dose (RP2D) of TBio-6517 when administered by direct injection into tumor(s) or intravenously and when combined with pembrolizumab in patients…NCT04301011·Phoenix, Arizona and 10 others

CompletedVaccine Therapy With or Without Biological Therapy in Treating Patients With Metastatic MelanomaRATIONALE: Vaccines may make the body build an immune response to kill tumor cells.NCT00006385·Scottsdale, Arizona and 31 others

Page 1 of 19Next

Other Conditions in Massachusetts

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Leukemia Lymphoma